Substance Dependence

4

Review clinical trials related to Substance Dependence. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Neuroimaging of Adolescent Cannabis Use Treatment

This study is testing whether brain activity related to learning can help predict how well teens respond to a treatment program designed to reduce cannabis use. Teens ages 14-17 will complete a brain scan and then take part in 10 weekly virtual sessions where they report cannabis use and complete drug tests at home. Participants can earn prizes for staying cannabis-free.

Participants needed: 80
Trial details
Age: 14-17Biological sex: AllType: InterventionalSponsor: Indiana UniversityUpdated: Jun 22, 2026Locations: 1
Eligibility criteria

14-17 year old youth [+3]

Youth has a history of Fetal Alcohol Spectrum Disorder, intellectual disorders,... [+3]

Status: Recruiting

Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees

The aim of Health Surveillance is to analyze and describe the state of health of students at Constructor University, key influencing factors and individual resources by using mixed-method design.

Participants needed: 363
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Jacobs University Bremen gGmbHUpdated: May 1, 2026Locations: 2
Eligibility criteria

English language skills [+4]

Illiteracy [+1]

Status: Recruiting

Pre-exposure Prophylaxis (PrEP) for Health

This randomized controlled trial will test the efficacy of "PrEP for Health," a behavioral intervention to improve the use of antiretroviral pre-exposure prophylaxis (PrEP) among at-risk people who inject drugs (PWID) in two syringe service program (SSP) settings in Lawrence and Boston/Cambridge, Massachusetts. The investigators will equally randomize 200 PWID to receive either (a) the "PrEP for Health" intervention condition involving theory-informed HIV and PrEP education, motivational interviewing, problem-solving and planning, and ongoing patient navigation (n=100), or (b) the standard of care condition involving PrEP information and referrals (n=100). Successful PrEP uptake (via medical/pharmacy records), post-treatment PrEP adherence (assessed at 3 months via drug levels in hair), and longer-term PrEP adherence (assessed at 6 and 12 months via drug levels in hair) will be evaluated. The degree to which intervention efficacy occurs through specific conceptual mediators and differs according to hypothesized moderators will also be evaluated.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Brown UniversityUpdated: May 4, 2025Locations: 2
Eligibility criteria

HIV-uninfected (verified by rapid/4th generation test) [+4]

Unable to provide informed consent due to severe mental or physical illness, cog... [+2]

Status: Recruiting

A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs

In addition to the well-known toxicological harms of intravenous drug (IVD) use, there can also be local tissue complications, including infections, venous sclerosis, tissue necrosis, and drug needle fragment retentions. Drug needle fragments in subcutaneous tissue may cause local symptoms (usually pain and infections), but they have also been identified as causing emboli to organs. The literature has described numerous case reports of people who inject drugs (PWIDs) and have retained needle fragments. The prevalence of the condition is not known, and the researchers therefore aim to perform the first cross-sectional study of PWIDs to estimate how common needle fragment retentions are and what their risk factors are in this population.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Tampere University HospitalUpdated: Jun 1, 2023Locations: 1
Eligibility criteria

History of intravenous drug use [+3]

No history of intravenous drug use [+3]